VT Co., Ltd. (KOSDAQ:018290)
18,860
-510 (-2.63%)
At close: Feb 6, 2026
VT Co., Ltd. Revenue
VT Co., Ltd. had revenue of 110.22B KRW in the quarter ending September 30, 2025, with 5.84% growth. This brings the company's revenue in the last twelve months to 434.59B, up 6.49% year-over-year. In the year 2024, VT Co., Ltd. had annual revenue of 431.70B with 46.09% growth.
Revenue (ttm)
434.59B
Revenue Growth
+6.49%
P/S Ratio
1.50
Revenue / Employee
1.90B
Employees
229
Market Cap
653.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 431.70B | 136.20B | 46.09% |
| Dec 31, 2023 | 295.50B | 55.26B | 23.00% |
| Dec 31, 2022 | 240.24B | 13.47B | 5.94% |
| Dec 31, 2021 | 226.77B | 119.37B | 111.15% |
| Dec 31, 2020 | 107.40B | -5.36B | -4.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmecca Korea | 590.81B |
| CLIO Cosmetics Co.,Ltd | 326.53B |
| C&C International | 271.51B |
| Englewood Lab | 204.62B |
| Manyo Factory | 118.72B |
| Icure Pharmaceutical Incorporation | 93.22B |
| Genic | 85.47B |
| Coreana Cosmetics | 76.53B |